Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dr. E. Gräub is a long-standing Swiss veterinary pharmaceutical company headquartered in Bern, specializing in the development and distribution of animal health products. Founded in 1920, the company offers a comprehensive portfolio that includes vaccines, anesthetics, anti-infectives, and nutritional supplements for both livestock and companion animals. Since 2006, it has operated as a subsidiary of the LIVISTO Group, integrating into a global network of veterinary specialists. While the company announced the cessation of its local manufacturing operations in Bern by the end of 2024, it remains a vital commercial and regulatory hub for the Swiss veterinary market. Dr. E. Gräub continues to support veterinarians through its extensive product range and educational initiatives like the HappyVet Project.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dr. E. Gräub.